At Lung Cancer Europe (LuCE), our vision is to ensure that all Europeans affected by lung cancer have equitable access to optimal care, leading to the best possible outcomes and quality of life.
We are dedicated to advocating for healthcare policies that prioritize equity. Our mission is to ensure that every individual facing lung cancer can benefit from the latest advancements in medical research and innovative healthcare practices, irrespective of where they live in Europe.
By creating our LuCE Access to Treatment Atlas, we hope to offer an invaluable tool to all stakeholders in the European lung cancer advocacy community. An initiative designed principally for our member organizations across Europe, we hope that this map of access to treatments will prove an effective support for all advocacy efforts at both national, regional and European levels.
Access to treatment may also be possible through clinical trials. For more information see:
https://accelerating-clinical-trials.europa.eu/index_en
In order to find a clinical trial you can use this interactive map:
https://euclinicaltrials.eu/search-for-clinical-trials/trial-map/?lang=en
In order to enhance early diagnosis, lung cancer screening programmes are incorporated in different countries. To know more about these programmes and find out where they are currently undergoing, see:
https://www.lungcancerpolicynetwork.com/interactive-map-of-lung-cancer-screening/
